# Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effects-of-the-anti-rankl-antibody-denosumab-on-joint-structural-damage-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tsutomu Takeuchi,Yoshiya Tanaka,Satoshi Soen,Hisashi Yamanaka,Toshiyuki Yoneda,Sakae Tanaka,Takaya Nitta,Naoki Okubo,Harry K. Genant,Désirée van der Heijde |
| Citations | 140 |
| DOI | 10.1136/annrheumdis-2018-214827 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/78/7/899.full.pdf |
| OpenAlex ID | https://openalex.org/W2943342119 |
| PMID | 31036625 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Satoshi Soen](https://scholariq.org/researchers/satoshi-soen/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.